Skip to main content
. 2021 Feb 22;60(14):2207–2216. doi: 10.2169/internalmedicine.6620-20

Table 2.

Number of Patients Treated with First, and Second-line TKIs.

2nd line TKI
no change Imatinib Nilotnib Dasatinib Bostinib
1st line TKI
(number of
patients)
Imatinib (170) 109 - 36 25 0
Nilotnib (41) 31 4 - 5 1
Dasatinib (52) 44 3 5 - 0
Bostinib (1) 1 0 0 0 -

TKI: tyrosine kinase inhibitor